Alta Biopharma Partners II, L.P.
Alta Partners · adviser of record: Alta Partners IV, Inc. · 2011 vintage
Alta Biopharma Partners II, L.P. is a 2011 venture fund managed by Alta Partners. It reported $38.8mm in gross assets at year-end 2019, against a peak of $88.9mm in 2015.
- Latest value held
- $38.8mm year-end 2019
- Peak
- $88.9mm year-end 2015
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2019 | $38.8mm | – | -32% |
| 2018 | $57.4mm | – | -6% |
| 2017 | $61.1mm | – | -20% |
| 2016 | $76.3mm | – | -14% |
| 2015 | $88.9mm | – | +22% |
| 2014 | $72.9mm | – | +85% |
| 2013 | $39.4mm | – | +17% |
| 2012 | $33.7mm | – | +1% |
| 2011 | $33.3mm | – | – |
Other funds from Alta Partners
- Alta Partners Nextgen Fund III, L.P. 2020
- Altadh Holdings, L.P. 2020
- Alta Partners Nextgen Fund II, L.P. 2018
- Alta Partners Nextgen Fund I, L.P. 2016
- Alta Partners VIII, L.P. 2011
- Alta Biopharma Partners III, L.P. 2011
- Acp IV, L.P. 2011
- Alta California Partners III, L.P. 2011
- Alta California Partners II, L.P. 2011
- Alta Biopharma Partners III GMBH & CO. Beteiligungs KG 2011
- Alta Embarcadero Biopharma Partners III, LLC 2011
- Alta Embarcadero Biopharma Partners II, LLC 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-8988995508. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.